|
Volumn 12, Issue 4, 2014, Pages 2308-2325
|
Design, synthesis and biological evaluation of tasiamide analogues as tumor inhibitors
|
Author keywords
Analogues; Cytotoxicity; Marine peptide; Synthesis; Tasiamide
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ETOPOSIDE;
TASIAMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
OLIGOPEPTIDE;
TASIAMIDE;
AMINO TERMINAL SEQUENCE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL LINE;
CANCER INHIBITION;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
ELIMINATION REACTION;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
LUNG NON SMALL CELL CANCER;
NASOPHARYNX CARCINOMA;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMISTRY;
IC50;
LUNG NEOPLASMS;
NASOPHARYNGEAL NEOPLASMS;
PATHOLOGY;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL LINE, TUMOR;
HUMANS;
INHIBITORY CONCENTRATION 50;
LUNG NEOPLASMS;
NASOPHARYNGEAL NEOPLASMS;
OLIGOPEPTIDES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84900461536
PISSN: None
EISSN: 16603397
Source Type: Journal
DOI: 10.3390/md12042308 Document Type: Article |
Times cited : (10)
|
References (9)
|